Periodic Reporting for period 2 - ZECARDIO (Cardiotoxicity High-throughput screening (HTS) with zebrafish embryo)

Summary
The complex nature of pharmaceutical new molecules generation, both in terms of R&D process and regulatory requirements, indicates a huge need for innovative tools/services for optimal delivery to patients of novel medicines in the fastest and cheapest manner. The...
More information & hyperlinks